Figure 1 | Scientific Reports

Figure 1

From: In vitro performances of novel co-spray-dried azithromycin/rifampicin microparticles for Rhodococcus equi disease treatment

Figure 1

Morphological analysis of the obtained spray-dried powders of AZM and RIF and their combinations in comparison with the commercial powders. AZM/RIF MP 1:2 (a,1a), AZM/RIF MP 2:1 (b,1b), AZM/RIF MP 1:1 (c,1c), RIF MP (d,1d), AZM MP (e,1e), commercial RIF powder (f,1f), commercial AZM powder (g,1g). Measurements were performed at 2 kV and images are reported between 0.4–38 kX magnifications.

Back to article page